A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Clinical trial NCT05667142 · RECRUITING
Trial details
- NCT number
- NCT05667142
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2027-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.